Verwey, Charl
Dangor, Ziyaad
Madhi, Shabir A.
Funding for this research was provided by:
University of the Witwatersrand
Article History
Accepted: 8 November 2023
First Online: 30 November 2023
Declarations
:
: Open access funding provided by University of the Witwatersrand. CV: Previously received personal funding from AstraZeneca, Merck, Cipla, and GSK. SAM and ZD: Grant support to institution from BMGF; involved in clinical trials with Pfizer, GSK, Merck, and AstraZeneca, with funding to institution. CV, ZD, and SAM are involved with a clinical trial for Enanta Pharmaceuticals. No funding was received for the preparation of this article.
: CV, SAM, and ZD declare no conflicts of interest related to this article.
: All data represented are available in the public domain.
: No ethics approval was required.
: Patient consent not applicable.
: This article is the sole work of the authors. CV, SAM, and ZD contributed equally to the planning, development, writing, and final approval of the manuscript.
: Not applicable
: Not applicable